Modulators of the H3 receptor useful for the treatment of disorders related thereto

Details for Australian Patent Application No. 2006316609 (hide)

Owner Arena Pharmaceuticals, Inc.

Inventors Santora, Vincent J.; Covel, Jonathan A.; Webb, Robert R.; Semple, Graeme; Hayashi, Rena; Ren, Albert S.; Weinhouse, Michael I.; Pulley, Michelle; Chen, Weichao G.; Ibarra, Jason B.; Duffield, Jonathan J.

Agent FB Rice

Pub. Number AU-A-2006316609

PCT Pub. Number WO2007/061741

Priority 60/737,624 17.11.05 US

Filing date 16 November 2006

Wipo publication date 31 May 2007

International Classifications

C07D 209/52 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/403 (2006.01) - condensed with carbocyclic rings, e.g. carbazole

A61K 31/422 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/4402 (2006.01) - only substituted in position 2, e.g. pheniramine, bisacodyl

A61K 31/4406 (2006.01) - only substituted in position 3, e.g. zimeldine

A61K 31/4409 (2006.01) - only substituted in position 4, e.g. isoniazid, iproniazid

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 403/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/10 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

5 June 2008 PCT application entered the National Phase

  PCT publication WO2007/061741 Priority application(s): WO2007/061741

2 December 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006316610-Delta-9 elongases and their use in making polyunsaturated fatty acids

2006316607-Pharmaceutical compositions comprising buprenorphine